Chikungunya virus RNA PCR is a molecular diagnostic test that detects the presence of chikungunya virus RNA in a patients blood sample.Its a highly sensitive and specific test that can confirm chikungunya infection within the first week of symptoms, when other diagnostic methods may be inconclusive. The test involves extracting viral RNA from the blood sample, amplifying it using a technique called reverse transcription-polymerase chain reaction (RT-PCR), and detecting specific viral sequences using fluorescent probes. A positive result indicates active chikungunya infection, while a negative result does not rule out the possibility of infection, especially if the sample was collected after the first week of illness.

MALARIA IS A MOSQUITO BORNE PARASITIC INFECTION SPREAD BY FEMALE ANOPHELES MOSQUITO INFECTED BY PLASMODIUM / MALARIAL PARASITE. MALARIA IS TRANSMITTED BY THE BITE OF AN INFECTED MOSQUITO; IF YOU RECEIVE INFECTED BLOOD TRANSFUSION FROM A MALARIA PATIENT; FROM AN INFECTED MOTHER TO THE BABY DURING PREGNANCY. THIS IS A SENSITIVE ASSAY FOR THE DETECTION OF MALARIAL PARASITE IN BLOOD SAMPLES.

TYPHOID FEVER IS A BACTERIAL INFECTION THAT SPREADS THROUGH CONTAMINATED FOOD & DRINKING WATER. IT CAN ALSO SPREAD THROUGH CLOSE CONTACT FROM ONE PERSON TO ANOTHER. THE DISEASE MAINLY AFFECTS INTESTINAL TRACT, LIVER AND SPLEEN. THIS TEST DETECTS IGM & IGG ANTIBODIES, THE MARKERS OF EXPOSURE TO TYPHOID BACTERIA.

NLR (NEUTROPHIL LYMPHOCYTE RATIO) IS A MEANINGFUL PARAMETER FOR PROGNOSIS AND RISK STRATIFICATION IN PATIENTS INFECTED WITH COVID-19. IT IS AN INDEPENDENT RISK FACTOR FOR CRITICAL ILLNESS IN PATIENTS WITH COVID-19.

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IS THE CAUSATIVE AGENT OF CORONAVIRUS DISEASE 2019 (COVID-19). IT IS AN INFECTIOUS DISEASE FIRST IDENTIFIED IN 2019 IN WUHAN, THE CAPITAL OF CHINAS HUBEI PROVINCE. IT HAS SPREAD GLOBALLY, RESULTING IN THE 2019 2020 CORONAVIRUS PANDEMIC. COMMON SYMPTOMS INCLUDE FEVER, COUGH, SHORTNESS OF BREATH, MUSCLE PAIN, SPUTUM PRODUCTION, DIARRHOEA, SORE THROAT, ABDOMINAL PAIN, AND LOSS OF SMELL OR TASTE. MAJORITY OF CASES RESULT IN MILD SYMPTOMS WHILE IN A FEW CASES IT MAY PROGRESS TO PNEUMONIA AND MULTI-ORGAN FAILURE. THE VIRUS IS MAINLY SPREAD DURING CLOSE CONTACT VIA RESPIRATORY DROPLETS PRODUCED WHEN PEOPLE COUGH OR SNEEZE.